Survey – new reporting requirements for ongoing use of ilium Methocarbamol injection
31 Jan 2023
Troy Animal Healthcare have recently been successful in renewing their Minor Use Permit to enable the ongoing supply of ilium Methocarbamol injection to veterinarians, until 30th June 2025.
This was in response to feedback from the profession indicating the importance of ongoing access to this medicine.
However, the Australian Pesticides and Veterinary Medicines Authority (APVMA) have introduced a new reporting requirement which means that veterinarians will need to submit case records to the manufacturer for every treatment performed (including the date, dosage administered, patient outcome).
If these compliance requirements are not met, then the permit will not be renewed in 2025 and the profession will lose access to this medicine.
Submission of case details can be done via the form on Troy’s website, which can be accessed via a QR Code (on the product packaging and the product Request Form).
Alternatively, the form can be accessed directly at https://troylab.com.au/methocarbamol
We are seeking your feedback on how this may impact you, given that there will be an increased time commitment to perform the case reporting.
We also wish to understand the importance of this medicine to the profession, its patterns of use and general requirement into the future.
Please take five to ten minutes to answer the survey at the following link: